Financials
- Market Capitalization 11.49 B
- Employee 711
- Founded 2004
- CEO Christopher Richard Anzalone
- Website www.arrowheadpharma.com
- Headquarter Delaware, United States
- FIGI BBG000BRVKH0
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-37.39
売上高対価格比率
16.85
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 812 | CORT Corcept Therapeutics Incorporated - Common Stock | 112.49 USD | -1.22% | -7.36% | -1.46% | +53.32% | 12.16 B USD | ||
| 822 | HALO Halozyme Therapeutics, Inc. - Common Stock | 106.09 USD | +0.70% | -1.32% | +28.44% | +58.82% | 12.04 B USD | ||
| 848 | TECH Bio-Techne Corp - Common Stock | 72.33 USD | -0.03% | -0.01% | +0.26% | +33.52% | 11.34 B USD | ||
| 865 | SMMT Summit Therapeutics Inc. - Common Stock | 13.64 USD | -0.66% | +8.08% | +5.33% | -31.32% | 10.88 B USD |